Come up with a name for your new list and we'll add to it:
Arbovax raised a round of funding on January 01, 2014. Investors include
Wilmington Investor Network.
Arbovax has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology through partnerships with …